Chanda Sanjay sold ANTX

January 6, 2026 · Form 4 insider transaction

Chanda Sanjay sold 5,956 shares of AN2 Therapeutics, Inc. at $1.01 per share, a transaction worth $6.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
5,956
Price
$1.01
Total value
$6.0K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2026
Filing dateJanuary 7, 2026
Shares owned after75,823
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026.; Includes (a) 27,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) 50,250 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.; Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's Employee Stock Purchase Plan on September 30, 2025.

View the original Form 4 on SEC EDGAR
Chanda Sanjay sold ANTX: January 6, 2026 | Insider Trading Screener